Showing results (521-530 of 749) with videos related to

Sort By:
Pageof 75
JMIR Formative Research|December 23, 2024
Medical Marijuana Documentation Practices in Patient Electronic Health Records: Retrospective Observational Study Using Smart Data Elements and a Review of Medical RecordsDonielle Beiler, Aanya Chopra, Christina M Gregor, et al.
Open Medicine (Warsaw, Poland)|December 18, 2019
Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two TimesAntonello Sica, Paola Vitiello, Alfonso Papa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectivesE Martinelli, D Ciardiello, G Martini, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|July 1, 2022
Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNPEugenio De Corso, Silvia Baroni, Maria Elisabetta Onori, et al.
Experimental Parasitology|May 6, 2008
Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite deathLivia Pica-Mattoccia, Tiziana Orsini, Annalisa Basso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2013
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell linesFloriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, et al.
Cancers|October 21, 2020
Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of RarβGabriela Paroni, Adriana Zanetti, Maria Monica Barzago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with CetuximabStefania Napolitano, Giulia Martini, Barbara Rinaldi, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
Oncology Reports|February 13, 2003
External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of lifeGiuseppe Di Lorenzo, Riccardo Autorino, Fortunato Ciardiello, et al.
Pageof 75